Banerjee Subhashis
SEC insider (Form 3/4/5 filer). CIK 0002065633. Chief Medical Officer at Artiva Biotherapeutics, Inc. (ARTV). 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in SAN DIEGO, CA.
Companies Banerjee Subhashis has filed insider reports for
- Artiva Biotherapeutics, Inc. (ARTV): Officer, Chief Medical Officer
Banerjee Subhashis
CIK: 0002065633
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Artiva Biotherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 5, 2026ARTV
Artiva Biotherapeutics, Inc.
SaleDirect1.1K shares at avg. $6.84$8K - Sep 9, 2026ARTV
Artiva Biotherapeutics, Inc.
AwardDirect30K shares- - Sep 3, 2026ARTV
Artiva Biotherapeutics, Inc.
SaleDirect1.1K shares at avg. $11.16$12K - Aug 18, 2026ARTV
Artiva Biotherapeutics, Inc.
ExerciseDirect429 shares at avg. $1.92$823.68 - Aug 18, 2026ARTV
Artiva Biotherapeutics, Inc.
SaleDirect429 shares at avg. $12.00$5K - May 19, 2026ARTV
Artiva Biotherapeutics, Inc.
SaleDirect7K shares at avg. $9.01$63K - Feb 15, 2026ARTV
Artiva Biotherapeutics, Inc.
AwardDirect102K shares- - Apr 8, 2025ARTV
Artiva Biotherapeutics, Inc.
AwardDirect50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale | 1,099 | $6.84 | $7,514 | Direct |
| Sep 9, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award | 30,000 | - | $0 | Direct |
| Sep 3, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale | 1,100 | $11.16 | $12,271 | Direct |
| Aug 18, 2026 | ARTV Artiva Biotherapeutics, Inc. | Exercise | 429 | $1.92 | $824 | Direct |
| Aug 18, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale | 429 | $12.00 | $5,148 | Direct |
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc. | Sale | 7,037 | $9.01 | $63,386 | Direct |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc. | Award | 102,000 | - | $0 | Direct |
| Apr 8, 2025 | ARTV Artiva Biotherapeutics, Inc. | Award | 50,000 | - | - | Direct |
1-8 of 8 transactions